Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma
Peking University
Peking University
Hoffmann-La Roche
Lokon Pharma AB
Amgen
Corcept Therapeutics
Genelux Corporation
AbbVie
Trishula Therapeutics, Inc.
Peking University People's Hospital
Theriva Biologics SL
iOnctura
Trishula Therapeutics, Inc.
Emory University
Cantargia AB
MedImmune LLC
Fondazione Michelangelo
Sumitomo Pharma America, Inc.
Medical College of Wisconsin
Celgene
ETOP IBCSG Partners Foundation
Seagen Inc.
Kyntra Bio
AbbVie
ERYtech Pharma
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Genentech, Inc.
Lumos Pharma
Altor BioScience
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Novartis
GlaxoSmithKline
Hoffmann-La Roche
Hellenic Oncology Research Group
University of California, San Francisco